{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:34:35Z","timestamp":1783953275021,"version":"3.55.0"},"reference-count":47,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPD"],"published-print":{"date-parts":[[2020,7,28]]},"DOI":"10.3233\/jpd-201988","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T11:39:05Z","timestamp":1590147545000},"page":"1003-1010","source":"Crossref","is-referenced-by-count":28,"title":["Serum Uric Acid Levels and Non-Motor Symptoms in Parkinson\u2019s Disease"],"prefix":"10.1177","volume":"10","author":[{"given":"Daniel J.","family":"van Wamelen","sequence":"first","affiliation":[{"name":"King\u2019s College London, Department of Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, De Crespigny Park, London, United Kingdom"},{"name":"Parkinson Foundation Centre of Excellence, King\u2019s College Hospital, Denmark Hill, London, United Kingdom"},{"name":"Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel N.","family":"Taddei","sequence":"additional","affiliation":[{"name":"King\u2019s College London, Department of Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, De Crespigny Park, London, United Kingdom"},{"name":"Parkinson Foundation Centre of Excellence, King\u2019s College Hospital, Denmark Hill, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Calvano","sequence":"additional","affiliation":[{"name":"King\u2019s College London, Department of Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, De Crespigny Park, London, United Kingdom"},{"name":"Parkinson Foundation Centre of Excellence, King\u2019s College Hospital, Denmark Hill, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya","family":"Titova","sequence":"additional","affiliation":[{"name":"Federal State Autonomous Educational Institution of Higher Education \u00abN.I. Pirogov Russian National Research Medical University\u00bb of the Federal Medical Biological Agency, Department of Neurology, Neurosurgery and Medical Genetics, Moscow, Russia"},{"name":"Federal State Budgetary Institution \u00abFederal center of brain and neurotechnologies\u00bb of the Ministry of Health of the Russian Federation, Department of Neurodegenerative Diseases, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Leta","sequence":"additional","affiliation":[{"name":"King\u2019s College London, Department of Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, De Crespigny Park, London, United Kingdom"},{"name":"Parkinson Foundation Centre of Excellence, King\u2019s College Hospital, Denmark Hill, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Shtuchniy","sequence":"additional","affiliation":[{"name":"Federal State Autonomous Educational Institution of Higher Education \u00abN.I. Pirogov Russian National Research Medical University\u00bb of the Federal Medical Biological Agency, Department of Neurology, Neurosurgery and Medical Genetics, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Jenner","sequence":"additional","affiliation":[{"name":"King\u2019s College London, Institute of Pharmaceutical Science, Hodgkin Building, Guy\u2019s Campus, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Martinez-Martin","sequence":"additional","affiliation":[{"name":"Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Carlos III Institute of Health, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Katunina","sequence":"additional","affiliation":[{"name":"Federal State Autonomous Educational Institution of Higher Education \u00abN.I. Pirogov Russian National Research Medical University\u00bb of the Federal Medical Biological Agency, Department of Neurology, Neurosurgery and Medical Genetics, Moscow, Russia"},{"name":"Federal State Budgetary Institution \u00abFederal center of brain and neurotechnologies\u00bb of the Ministry of Health of the Russian Federation, Department of Neurodegenerative Diseases, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Ray","family":"Chaudhuri","sequence":"additional","affiliation":[{"name":"King\u2019s College London, Department of Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, De Crespigny Park, London, United Kingdom"},{"name":"Parkinson Foundation Centre of Excellence, King\u2019s College Hospital, Denmark Hill, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JPD-201988_ref1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJM197110072851515","article-title":"Hyperuricemia and levodopa","volume":"285","author":"al-Hujaj","year":"1971","journal-title":"N Engl J Med"},{"key":"10.3233\/JPD-201988_ref2","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/oxfordjournals.aje.a008954","article-title":"Observations on serum uric acid levels and the risk of idiopathic Parkinson\u2019s disease","volume":"144","author":"Davis","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.3233\/JPD-201988_ref3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.20663","article-title":"Serum uric acid levels and the risk of Parkinson disease","volume":"58","author":"de Lau","year":"2005","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-201988_ref4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/aje\/kwm127","article-title":"Plasma urate and risk of Parkinson\u2019s disease","volume":"166","author":"Weisskopf","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.3233\/JPD-201988_ref5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.rdc.2014.01.005","article-title":"Comorbidities in patients with crystal diseases and hyperuricemia","volume":"40","author":"Sattui","year":"2014","journal-title":"Rheum Dis Clin North Am"},{"key":"10.3233\/JPD-201988_ref6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000323265","article-title":"Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson\u2019s disease: Changes linked to disease progression","volume":"8","author":"Ikeda","year":"2011","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JPD-201988_ref7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/bs.irn.2017.03.003","article-title":"Biomarkers of Parkinson\u2019s disease: An introduction","volume":"132","author":"Titova","year":"2017","journal-title":"Int Rev Neurobiol"},{"key":"10.3233\/JPD-201988_ref8","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1007\/s12035-015-9271-6","article-title":"Inverse association between serum uric acid levels and Alzheimer\u2019s disease risk","volume":"53","author":"Du","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JPD-201988_ref9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ene.12533","article-title":"Presence and progression of non-motor symptoms in relation to uric acid in de novo Parkinson\u2019s disease","volume":"22","author":"Moccia","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.3233\/JPD-201988_ref10","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41598-018-19609-2","article-title":"Serum uric acid levels in patients with amyotrophic lateral sclerosis: A meta-analysis","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci Rep"},{"key":"10.3233\/JPD-201988_ref11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000346606","article-title":"The relation of uric acid to brain atrophy and cognition: The Rotterdam Scan Study","volume":"41","author":"Verhaaren","year":"2013","journal-title":"Neuroepidemiology"},{"key":"10.3233\/JPD-201988_ref12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.5694\/mja17.00993","article-title":"Non-motor Parkinson disease: New concepts and personalised management","volume":"208","author":"Titova","year":"2018","journal-title":"Med J Aust"},{"key":"10.3233\/JPD-201988_ref13","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ana.23687","article-title":"Meta-analysis of early nonmotor features and risk factors for Parkinson disease","volume":"72","author":"Noyce","year":"2012","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-201988_ref14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00702-016-1667-6","article-title":"Parkinson\u2019s: A syndrome rather than a disease?","volume":"124","author":"Titova","year":"2017","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JPD-201988_ref15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: Diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.3233\/JPD-201988_ref16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/mds.23462","article-title":"The impact of non-motor symptoms on health-related quality of life of patients with Parkinson\u2019s disease","volume":"26","author":"Martinez-Martin","year":"2011","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-201988_ref17","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson\u2019s disease","volume":"24","author":"Barone","year":"2009","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-201988_ref18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.parkreldis.2011.01.013","article-title":"Uric acid and cognition in Parkinson\u2019s disease: A follow-up study","volume":"17","author":"Annanmaki","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-201988_ref19","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson\u2019s disease","volume":"30","author":"Berg","year":"2015","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-201988_ref20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.parkreldis.2018.05.010","article-title":"Serum uric acid level and its association with motor subtypes and non-motor symptoms in early Parkinson\u2019s disease: PALS study","volume":"55","author":"Huang","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-201988_ref21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00702-015-1502-5","article-title":"Serum uric acid is associated with apathy in early, drug-naive Parkinson\u2019s disease","volume":"123","author":"Picillo","year":"2016","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JPD-201988_ref22","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1007\/s00415-019-09325-w","article-title":"Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson\u2019s disease","volume":"266","author":"van Wamelen","year":"2019","journal-title":"J Neurol"},{"key":"10.3233\/JPD-201988_ref23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mds.21837","article-title":"A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson\u2019s disease","volume":"23","author":"Zadikoff","year":"2008","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-201988_ref24","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archpsyc.1983.01790060110016","article-title":"The Mini-Mental State Examination","volume":"40","author":"Folstein","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JPD-201988_ref25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.3233\/JPD-201988_ref26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/mds.10656","article-title":"Health-related quality of life evaluation by proxy in Parkinson\u2019s disease: Approach using PDQ-8 and EuroQoL-5D","volume":"19","author":"Martinez-Martin","year":"2004","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-201988_ref27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/jnnp.73.6.629","article-title":"The Parkinson\u2019s disease sleep scale: A new instrument for assessing sleep and nocturnal disability in Parkinson\u2019s disease","volume":"73","author":"Chaudhuri","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JPD-201988_ref28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: Onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.3233\/JPD-201988_ref29","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jnnp.2003.017509","article-title":"A short scale for the assessment of motor impairments and disabilities in Parkinson\u2019s disease: The SPES\/SCOPA","volume":"75","author":"Marinus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JPD-201988_ref30","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/mds.21596","article-title":"The metric properties of a novel non-motor symptoms scale for Parkinson\u2019s disease: Results from an international pilot study","volume":"22","author":"Chaudhuri","year":"2007","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-201988_ref31","doi-asserted-by":"crossref","first-page":"e57221","DOI":"10.1371\/journal.pone.0057221","article-title":"A proposal for a comprehensive grading of Parkinson\u2019s disease severity combining motor and non-motor assessments: Meeting an unmet need","volume":"8","author":"Ray Chaudhuri","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JPD-201988_ref32","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00702-015-1437-x","article-title":"Quantitative assessment of non-motor fluctuations in Parkinson\u2019s disease using the Non-Motor Symptoms Scale (NMSS)","volume":"122","author":"Storch","year":"2015","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JPD-201988_ref33","doi-asserted-by":"crossref","first-page":"e0173731","DOI":"10.1371\/journal.pone.0173731","article-title":"Serum uric acid levels in patients with Parkinson\u2019s disease: A meta-analysis","volume":"12","author":"Wen","year":"2017","journal-title":"PLoS One"},{"key":"10.3233\/JPD-201988_ref34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1212\/WNL.0000000000002351","article-title":"Prospective study of plasma urate and risk of Parkinson disease in men and women","volume":"86","author":"Gao","year":"2016","journal-title":"Neurology"},{"key":"10.3233\/JPD-201988_ref35","doi-asserted-by":"crossref","first-page":"E761","DOI":"10.3390\/nu11040761","article-title":"Sleep duration is inversely associated with serum uric acid concentrations and uric acid to creatinine ratio in an elderly Mediterranean population at high cardiovascular risk","volume":"11","author":"Papandreou","year":"2019","journal-title":"Nutrients"},{"key":"10.3233\/JPD-201988_ref36","doi-asserted-by":"crossref","first-page":"E975","DOI":"10.3390\/nu10080975","article-title":"Uric acid and cognitive function in older individuals","volume":"10","author":"Tana","year":"2018","journal-title":"Nutrients"},{"key":"10.3233\/JPD-201988_ref37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.expneurol.2017.08.007","article-title":"Urate promotes SNCA\/alpha-synuclein clearance via regulating mTOR-dependent macroautophagy","volume":"297","author":"Sheng","year":"2017","journal-title":"Exp Neurol"},{"key":"10.3233\/JPD-201988_ref38","doi-asserted-by":"crossref","first-page":"470","DOI":"10.14336\/AD.2019.0330","article-title":"Novel insights on systemic and brain aging, stroke, amyotrophic lateral sclerosis, and Alzheimer\u2019s disease","volume":"10","author":"Shetty","year":"2019","journal-title":"Aging Dis"},{"key":"10.3233\/JPD-201988_ref39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev-pathol-051217-111018","article-title":"The glymphatic system in central nervous system health and disease: Past, present, and future","volume":"13","author":"Plog","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"10.3233\/JPD-201988_ref40","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.aav2546","article-title":"The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans","volume":"363","author":"Holth","year":"2019","journal-title":"Science"},{"key":"10.3233\/JPD-201988_ref41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.14336\/AD.2017.0416","article-title":"Trefoil factor 3, cholinesterase and homocysteine: Potential predictors for Parkinson\u2019s disease dementia and vascular parkinsonism dementia in advanced stage","volume":"9","author":"Zou","year":"2018","journal-title":"Aging Dis"},{"key":"10.3233\/JPD-201988_ref42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fnagi.2017.00026","article-title":"Plasma cystatin C and high-density lipoprotein are important biomarkers of Alzheimer\u2019s disease and vascular dementia: A cross-sectional study","volume":"9","author":"Wang","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JPD-201988_ref43","doi-asserted-by":"crossref","first-page":"834","DOI":"10.14336\/AD.2019.0304","article-title":"Plasma lipoprotein-associated phospholipase A2 and superoxide dismutase are independent predicators of cognitive impairment in cerebral small vessel disease patients: Diagnosis and assessment","volume":"10","author":"Zhu","year":"2019","journal-title":"Aging Dis"},{"key":"10.3233\/JPD-201988_ref44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JAD-2011-110587","article-title":"Serum and cerebrospinal fluid uric acid levels in lewy body disorders: Associations with disease occurrence and amyloid-beta pathway","volume":"27","author":"Maetzler","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JPD-201988_ref45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000342483","article-title":"Serum uric acid in patients with Parkinson\u2019s disease and vascular parkinsonism: A cross-sectional study","volume":"20","author":"Pan","year":"2013","journal-title":"Neuroimmunomodulation"},{"key":"10.3233\/JPD-201988_ref46","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/jcp.25509","article-title":"Uric acid amplifies Abeta amyloid effects involved in the cognitive dysfunction\/dementia: Evidences from an experimental model in vitro","volume":"232","author":"Desideri","year":"2017","journal-title":"J Cell Physiol"},{"key":"10.3233\/JPD-201988_ref47","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12017-012-8181-2","article-title":"Sleep disturbances in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"14","author":"Rothman","year":"2012","journal-title":"Neuromolecular Med"}],"container-title":["Journal of Parkinson's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JPD-201988","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:48:15Z","timestamp":1777610895000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JPD-201988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":47,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jpd-201988","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738008034.793578815","asserted-by":"object"}]},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,28]]}}}